The pump and dump on Cortronix Biomedical Advancement Technologies Inc. (CBAT) appears to have reached it’s target date to get thrown into the OTC arena. Having been on the shelf for all of this year with exception to a couple $100 worth of shares traded to bring down the price, CBAT stock saw some late afternoon action yesterday which coincides with how BDPS tends to operate. Although the activity wasn’t significant enough to create a real stir, the silk milk about how their Mobile Cardio Devices could save lives could cost longs a fortune.
Our Next Pick Is Coming Soon!
Click HERE To Make Sure You Don’t Miss Any Of Our Hot Penny Stock Alerts!
CBAT Stock Quote
Market Cap: 19.22M
Last: 0.055 ▼ -0.03 (-35.29%)
Dollar Volume: $35,619
Issued and Outstanding: 349,500,000
14-Day Rel Strength: 43.28%
1st Resistance Point: 0.085
1st Support Level: 0.04
Looking for the Best Penny Stocks to Buy?
Click HERE To Receive FREE Penny Stock Alerts
Nothing has come out from Cortronix Biomedical Advancement Technologies in over a year despite the fact that they hired Maplehurst Investment Group LLC to be their IR back in December, 2012. Actually, nothing at all has been happening really with either the Company or CBAT ever since they took over the shell corp of Pana-Minerales S.A. (PNMA).
No revenes have been booked by Cortronix Biomed and cash was non-existent as of their 10-Q filing for the 3 months ended November 30, 2013. However, during the period, at least 10,000,000 shares of CBAT were issued since they obviously can’t fund their $5,000 a month IR service agreement.
As per the last Q filing: On September 6, 2013, the Company entered into a consulting and investor relations agreement with Maplehurst Investment Group, LLC. Under the terms of the new agreement, the Company agreed to settle the outstanding amount of $40,000 under the contract with Maplehurst by way of the issuance of 10,000,000 shares of the common stock of the Company and Maplehurst agreed to provide services under the contract for an additional twelve month period for no further consideration. The shares were issued on November 19, 2013.
Richard Hull is the Managing Member of Maplehurst Investment Group, LLC. Not that this makes a huge difference if CBAT stock gets pumped or not by BDPS, but as it stands at 0.055, Richard Hull is sitting on $550,000 worth of CBAT stock for his $40,000 debt they had to his Maplehurst Investment Group and they still get another 12 months of extraordinary IR service on top of that.
But what Richard received was just a drop int he CBAT bucket.
Global Investment Strategies S.A. LLC, a company with offices in Saudi Arabia, was granted the exclusive license for the Middle East and is due to provide support, management and personnel to make strategic introductions to end users of the Cortronix technologies if and when they ever get their business plan up and running. For doing such, Global Investment Strategies S.A., on November 19, 2013, was issued 52,500,000 shares CBAT stock which Cortronix booked as marketing expense.
Right now, without pumping CBAT, those 52,500,000 shares are worth $2,887,500. Between them and Dick Hull’s Maplehurst, they could run CBAT into the ground to under 0.01 and they would still come out smelling like roses for doing absolutely NOTHING!
While Cortronix may be in the final stages of developing the infrastructure of their Global Health Network that will significantly increase the overall ability for Medical Professionals to properly diagnose and analyze patients’ data remotely and in real time, CBAT stock, should it be the pump pick today of BDPS, is due for a crash cart come tomorrow – just like all their other picks have done in the past year or so.
About CBAT Stock
CorTronix Biomedical Advancement Technologies, Inc., formerly Pana-Minerales S.A. (PNMA), is a development stage focused on the development of a proprietary technology known as Corlink, an advanced telemetric system used to transmit, analyze, report and store all types and variations of physiological studies.
Last 5 Trading Sessions:
CBAT is on the list of possible picks that Best Damn Penny Stocks is likely to be issuing as their pick today. Time and time again they have cancelled picks when they were due to issue them so be careful not to jump the gun on CBAT stock unless you’re prepared to wait another 6 months like some other fronters have already done.
Our Next Pick Is Coming Soon!
Text Keyword “AIMHIGH” To 99000 To Make Sure You Don’t Miss It!